Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer or Mild Cognitive Impairment”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableUnknownNCT05104593
What this trial is testing

An Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With Dementia

Who this might be right for
Comorbidities and Coexisting ConditionsAlzheimer DiseaseDementia+12 more
Complejo Hospitalario Universitario de Albacete 204
Very early researchActive Not RecruitingNCT04075435
What this trial is testing

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAnxietyAgitation,Psychomotor+1 more
Mclean Hospital 12
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Not applicableStudy completedNCT05383053
What this trial is testing

Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Neurozen Inc. 227
Early research (Phase 1)Looking for participantsNCT06786676
What this trial is testing

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Who this might be right for
Healthy
Amyloid Solution Inc 88
Early research (Phase 1)Study completedNCT02502253
What this trial is testing

BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Johns Hopkins University 14
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Early research (Phase 1)Not Yet RecruitingNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Not applicableStudy completedNCT07402590
What this trial is testing

Auditory Stimulation During Sleep to Enhance Long-Term Memory in Amnestic MCI

Who this might be right for
Mild Cognitive Impairment (MCI)Amnestic Mild Cognitive Impairment - aMCIAlzheimer or Mild Cognitive Impairment
Bitbrain 37
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Study completedNCT01661673
What this trial is testing

Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
FORUM Pharmaceuticals Inc 52
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Large-scale testing (Phase 3)Study completedNCT05108922
What this trial is testing

Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer Disease
Eli Lilly and Company 148
Not applicableWithdrawnNCT04901494
What this trial is testing

SSRI's and the Rate of Progression From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentDementiaAlzheimer Disease
Ohio State University
Early research (Phase 1)Study completedNCT01424436
What this trial is testing

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 19
Not applicableEnded earlyNCT05078437
What this trial is testing

Assessment of Medication Optimization in Rural Kentucky Appalachian Patients With Mild Cognitive Impairment or Dementia

Who this might be right for
DementiaMild Cognitive Impairment
Daniela Moga 16
Load More Results